| Purpose | Announcement Date | Meeting Date |
|---|---|---|
| EGM | 7 Jan 2026 | 31 Jan 2026 |
| The Board has approved the notice of the Extra-ordinary General Meeting of the Company (EGM) to be held on Saturday, January 31, 2026 at 12:30 P.M. (IST) through Video Conferencing (VC)/ Other Audio Video Means (OAVM) in accordance with the relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India, for obtaining the approval of the shareholders of the Company for the matter as discussed above and such other matters as necessary Senores Pharmaceuticals Limited has informed the Exchange regarding the Notice of the Extra-Ordinary General Meeting scheduled to be held on Saturday, January 31, 2026 (As per BSE Announcement dated on: 09.01.2026) Senores Pharmaceuticals Limited has informed the Exchange regarding the Scrutinizer Report and voting results of the Extra-Ordinary General Meeting of the Company. Senores Pharmaceuticals Limited has informed the Exchange regarding the proceedings of the Extra-Ordinary General Meeting of the Company. (As Per BSE Announcement Dated On : 31.01.2026) Senores Pharmaceuticals Limited has informed the Exchange regarding additional disclosures to the Notice of Extra-Ordinary General Meeting dated January 07, 2026. (As Per BSE Announcement Dated on 13.02.2026) | ||
The acquisition will be carried out in two tranches and has received approval from the management committee of the company’s board.
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
